Hey LD. I think the broader question is if the items highlighted by the FDA in the RTF are addressed, will Cort be approved? I am not familiar enough with the process. Also, I suppose the FDA can always claim a line item wasn’t addressed even in the new snda - hard to say as we don’t have any real knowledge of its contents. So the stock is saying that Cort is a zero. Why do we have reason to believe it is wrong?
Market Data 
Markets 
